Johnson & Johnson has agreed to pay $33 million (₹213 crore) to resolve charges by US states that it misrepresented manufacturing practices behind Benadryl and other over-the-counter drugs. This resolves claims related to many products including children's medicines, that were voluntarily recalled from 2009-2011. The settlement was announced by attorneys for 42 states and the District of Columbia.